Purpura, Thrombocytopenic - 15 Studies Found
| Completed |
: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) : Purpura, Thrombocytopaenic, Idiopathic : 2007-01-17 : Drug: eltrombopag experimental |
| Completed |
: A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) : Purpura, Thrombocytopaenic, Idiopathic : 2010-03-25 : Drug: Eltrombopag olamine Thrombopoietin receptor agonist |
| Completed |
: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients : Purpura, Thrombocytopenic, Idiopathic : 2015-03-20 : Drug: Hetrombopag Olamine Hetrombopag Olamine 2.5mg, 5mg and 7.5mg |
| Terminated |
: Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). : Purpura, Thrombocytopenic, Idiopathic : 2013-12-09 : Drug: BI 655064 subcutaneous injection |
| Completed |
: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers :
|
| Completed |
: Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura : Purpura, Thrombocytopenic, Idiopathic : 2000-05-02 : Drug: rituximab |
| Completed |
: Efficacy and Safety of IVIG-L in ITP Patients : Purpura, Thrombocytopenic, Idiopathic : 2005-09-08 : Drug: IVIG-L |
| Completed |
: Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP : Purpura, Thrombocytopenic, Idiopathic : 2005-09-13 : Drug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified IGIV-C 10% at a dose of 1.0g/kg |
| Completed |
: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) : Purpura, Thrombocytopaenic, Idiopathic : 2005-02-01 : Drug: SB497115 |